Non-invasive Nerve Stimulation for PTSD and Sleep
Launched by UNIVERSITY OF FLORIDA · May 25, 2017
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different types of non-invasive nerve stimulation can help improve sleep patterns in veterans who have Post Traumatic Stress Disorder (PTSD) and may also have experienced mild traumatic brain injuries. The goal is to see if these treatments can make a positive difference in how well participants sleep, which is often affected by PTSD.
To be eligible for this study, participants should be veterans aged 65 to 74 years who have a history of PTSD, with or without a mild brain injury. However, those with severe psychiatric illnesses unrelated to PTSD or traumatic brain injury, certain medical conditions that could affect thinking, or current substance abuse issues are not eligible to participate. If chosen, participants can expect to be part of a research effort that could lead to better treatments for sleep issues related to PTSD. The trial is currently recruiting, and all genders are welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • veterans with history of PTSD with and without history of mild TBI
- Exclusion Criteria with:
- • history of severe psychiatric illness unrelated to PTSD or TBI
- • other medical conditions of severity that may impair cognition
- • current illicit or prescription drug abuse
- • breathing disorder requiring constant use of oxygen
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Gainesville, Florida, United States
Jacksonville, Florida, United States
Gainesville, Florida, United States
Patients applied
Trial Officials
John Williamson, Ph.D.
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials